Lung Nodules in Melanoma Patients: Morphologic Criteria to Differentiate Non-Metastatic and Metastatic Lesions
- PMID: 34066913
- PMCID: PMC8148527
- DOI: 10.3390/diagnostics11050837
Lung Nodules in Melanoma Patients: Morphologic Criteria to Differentiate Non-Metastatic and Metastatic Lesions
Abstract
Lung nodules are frequent findings in chest computed tomography (CT) in patients with metastatic melanoma. In this study, we assessed the frequency and compared morphologic differences of metastases and benign nodules. We retrospectively evaluated 85 patients with melanoma (AJCC stage III or IV). Inclusion criteria were ≤20 lung nodules and follow-up using CT ≥183 days after baseline. Lung nodules were evaluated for size and morphology. Nodules with significant growth, nodule regression in line with RECIST assessment or histologic confirmation were judged to be metastases. A total of 438 lung nodules were evaluated, of which 68% were metastases. At least one metastasis was found in 78% of patients. A 10 mm diameter cut-off (used for RECIST) showed a specificity of 95% and a sensitivity of 20% for diagnosing metastases. Central location (n = 122) was more common in metastatic nodules (p = 0.009). Subsolid morphology (n = 53) was more frequent (p < 0.001), and calcifications (n = 13) were solely found in non-metastatic lung nodules (p < 0.001). Our data show that lung nodules are prevalent in about two-thirds of melanoma patients (AJCC stage III/IV) and the majority are metastases. Even though we found a few morphologic indicators for metastatic or non-metastatic lung nodules, morphology has limited value to predict the presence of lung metastases.
Keywords: malignant melanoma; multi-detector computed tomography; pulmonary nodules.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
The clinical significance of indeterminate pulmonary nodules in melanoma patients at baseline and during follow-up chest CT.Eur J Radiol Open. 2019 Feb 11;6:85-90. doi: 10.1016/j.ejro.2019.02.003. eCollection 2019. Eur J Radiol Open. 2019. PMID: 30805420 Free PMC article.
-
A proposed methodology for detecting the malignant potential of pulmonary nodules in sarcoma using computed tomographic imaging and artificial intelligence-based models.Front Oncol. 2023 Aug 21;13:1212526. doi: 10.3389/fonc.2023.1212526. eCollection 2023. Front Oncol. 2023. PMID: 37671060 Free PMC article.
-
Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT?Cancer Imaging. 2019 Jun 10;19(1):36. doi: 10.1186/s40644-019-0223-7. Cancer Imaging. 2019. PMID: 31182167 Free PMC article.
-
Diagnostic imaging in metastatic lung disease.Lung. 1990;168 Suppl:1129-36. doi: 10.1007/BF02718253. Lung. 1990. PMID: 2117114 Review.
-
[Surgery of pulmonary metastasis from malignant melanoma. Results and criteria of surgical excision].Ann Dermatol Venereol. 1991;118(4):287-95. Ann Dermatol Venereol. 1991. PMID: 2069340 Review. French.
Cited by
-
F-18 Fluoro-2-Deoxyglucose Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Melanoma: Normal Variants, Pitfalls, and Artifacts.Front Nucl Med. 2022 Mar 8;2:835404. doi: 10.3389/fnume.2022.835404. eCollection 2022. Front Nucl Med. 2022. PMID: 39354990 Free PMC article. Review.
-
Metastatic melanoma to the lung cured with lobectomy: A case report.Respir Med Case Rep. 2023 Mar 1;43:101826. doi: 10.1016/j.rmcr.2023.101826. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37008194 Free PMC article.
-
Cryoshocked Adipocytes Mediated Dual-Modal Strategy Combining Photodynamic Therapy and Triptolide Palmitate for Pulmonary Metastatic Melanoma Treatment.Adv Sci (Weinh). 2025 Mar;12(9):e2414307. doi: 10.1002/advs.202414307. Epub 2025 Jan 13. Adv Sci (Weinh). 2025. PMID: 39804941 Free PMC article.
-
[18F]-FDG PET-CT in Malignant Melanoma.Diagnostics (Basel). 2025 May 8;15(10):1192. doi: 10.3390/diagnostics15101192. Diagnostics (Basel). 2025. PMID: 40428185 Free PMC article.
References
-
- Belhocine T.Z., Scott A.M., Even-Sapir E., Urbain J.L., Essner R. Role of nuclear medicine in the management of cutaneous malignant melanoma. J. Nucl. Med. 2006;47:957–967. - PubMed
LinkOut - more resources
Full Text Sources